BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

224 related articles for article (PubMed ID: 34956317)

  • 1. Hereditary Multiple Exostoses-A Review of the Molecular Background, Diagnostics, and Potential Therapeutic Strategies.
    Bukowska-Olech E; Trzebiatowska W; Czech W; Drzymała O; Frąk P; Klarowski F; Kłusek P; Szwajkowska A; Jamsheer A
    Front Genet; 2021; 12():759129. PubMed ID: 34956317
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mutational screening of EXT1 and EXT2 genes in Polish patients with hereditary multiple exostoses.
    Jamsheer A; Socha M; Sowińska-Seidler A; Telega K; Trzeciak T; Latos-Bieleńska A
    J Appl Genet; 2014 May; 55(2):183-8. PubMed ID: 24532482
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hereditary multiple exostoses and enchondromatosis.
    Pannier S; Legeai-Mallet L
    Best Pract Res Clin Rheumatol; 2008 Mar; 22(1):45-54. PubMed ID: 18328980
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A novel mutation in ext2 caused hereditary multiple exostoses through reducing the synthesis of heparan sulfate.
    Xian C; Zhu M; Nong T; Li Y; Xie X; Li X; Li J; Li J; Wu J; Shi W; Wei P; Xu H; Tang YP
    Genet Mol Biol; 2021; 44(2):e20200334. PubMed ID: 34042151
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The pathogenic roles of heparan sulfate deficiency in hereditary multiple exostoses.
    Pacifici M
    Matrix Biol; 2018 Oct; 71-72():28-39. PubMed ID: 29277722
    [TBL] [Abstract][Full Text] [Related]  

  • 6. An optimized DHPLC protocol for molecular testing of the EXT1 and EXT2 genes in hereditary multiple osteochondromas.
    Wuyts W; Radersma R; Storm K; Vits L
    Clin Genet; 2005 Dec; 68(6):542-7. PubMed ID: 16283885
    [TBL] [Abstract][Full Text] [Related]  

  • 7. An update on the imaging of diaphyseal aclasis.
    Ellatif M; Sharif B; Lindsay D; Pollock R; Saifuddin A
    Skeletal Radiol; 2021 Oct; 50(10):1941-1962. PubMed ID: 33791832
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hereditary Multiple Exostoses: Current Insights.
    D'Arienzo A; Andreani L; Sacchetti F; Colangeli S; Capanna R
    Orthop Res Rev; 2019; 11():199-211. PubMed ID: 31853203
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hereditary Multiple Exostoses: a review of clinical appearance and metabolic pattern.
    Beltrami G; Ristori G; Scoccianti G; Tamburini A; Capanna R
    Clin Cases Miner Bone Metab; 2016; 13(2):110-118. PubMed ID: 27920806
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hereditary Multiple Exostoses: New Insights into Pathogenesis, Clinical Complications, and Potential Treatments.
    Pacifici M
    Curr Osteoporos Rep; 2017 Jun; 15(3):142-152. PubMed ID: 28466453
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Multiple hereditary exostoses (MHE): elucidating the pathogenesis of a rare skeletal disorder through interdisciplinary research.
    Jones KB; Pacifici M; Hilton MJ
    Connect Tissue Res; 2014 Apr; 55(2):80-8. PubMed ID: 24409815
    [TBL] [Abstract][Full Text] [Related]  

  • 12. 20 novel point mutations and one large deletion in EXT1 and EXT2 genes: report of diagnostic screening in a large Italian cohort of patients affected by hereditary multiple exostosis.
    Ciavarella M; Coco M; Baorda F; Stanziale P; Chetta M; Bisceglia L; Palumbo P; Bengala M; Raiteri P; Silengo M; Caldarini C; Facchini R; Lala R; Cavaliere ML; De Brasi D; Pasini B; Zelante L; Guarnieri V; D'Agruma L
    Gene; 2013 Feb; 515(2):339-48. PubMed ID: 23262345
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Compound heterozygous loss of Ext1 and Ext2 is sufficient for formation of multiple exostoses in mouse ribs and long bones.
    Zak BM; Schuksz M; Koyama E; Mundy C; Wells DE; Yamaguchi Y; Pacifici M; Esko JD
    Bone; 2011 May; 48(5):979-87. PubMed ID: 21310272
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Genotype-phenotype correlation in hereditary multiple exostoses.
    Francannet C; Cohen-Tanugi A; Le Merrer M; Munnich A; Bonaventure J; Legeai-Mallet L
    J Med Genet; 2001 Jul; 38(7):430-4. PubMed ID: 11432960
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Novel EXT1 mutation identified in a pedigree with hereditary multiple exostoses.
    Cao L; Liu F; Kong M; Fang Y; Gu H; Chen Y; Zhao C; Zhang S; Bi Q
    Oncol Rep; 2014 Feb; 31(2):713-8. PubMed ID: 24297320
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hereditary multiple exostoses caused by a chromosomal inversion removing part of EXT1 gene.
    Alexandrou A; Salameh N; Papaevripidou I; Nicolaou N; Myrianthopoulos P; Ketoni A; Kousoulidou L; Anastasiou AM; Evangelidou P; Tanteles GA; Sismani C
    Mol Cytogenet; 2023 May; 16(1):8. PubMed ID: 37217936
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Association of EXT1 and EXT2, hereditary multiple exostoses gene products, in Golgi apparatus.
    Kobayashi S; Morimoto K; Shimizu T; Takahashi M; Kurosawa H; Shirasawa T
    Biochem Biophys Res Commun; 2000 Feb; 268(3):860-7. PubMed ID: 10679296
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Advances in the pathogenesis and possible treatments for multiple hereditary exostoses from the 2016 international MHE conference.
    Phan AQ; Pacifici M; Esko JD
    Connect Tissue Res; 2018 Jan; 59(1):85-98. PubMed ID: 29099240
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hereditary multiple exostoses: are there new plausible treatment strategies?
    Pacifici M
    Expert Opin Orphan Drugs; 2018; 6(6):385-391. PubMed ID: 31448184
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 12.